Gastroesophageal Reflux Disease (GERD) Device Market Forecast by Diagnostic Devices, Manometry Systems, and Other Products From 2024 To 2034
Gastroesophageal Reflux Disease (GERD) Device Market Outlook
Around USD 1207.3 million is projected to be the value of global sales of gastroesophageal reflux disease (GERD) device in 2024. By 2034, the gastroesophageal reflux disease (GERD) device market is anticipated to advance at a 3.6% CAGR and surpass a valuation of USD 1719.5 million. The increasing prevalence of GERD and the development of less invasive treatment options are projected to contribute to the gastroesophageal reflux disease device market's steady rise.
Technological advancements such as endoscopic therapy and magnetic sphincter augmentation devices are becoming a growing trend since they provide efficient substitutes for conventional surgical and pharmaceutical methods. The gastroesophageal reflux disease (GERD) device market is expanding due to patients and healthcare professionals becoming conscious of the advantages of these devices, which include quicker recovery times and enhanced quality of life.
Attributes
Details
Market Value for 2024
USD 1207.3 million
Market Value for 2034
USD 1719.5 million
Market CAGR from 2024 to 2034
3.6%
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Growth Avenues in the Gastroesophageal Reflux Disease (GERD) Device Market
Due to parameters like patient preference, cost-effectiveness, and convenience, ambulatory care and outpatient operations are progressively prevalent. This trend is particularly suited for gastroesophageal reflux disease (GERD) devices utilized in minimally invasive treatments or outpatient settings.
Pressure is on healthcare systems to reduce costs and enhance patient outcomes. In the long run, gastroesophageal reflux disease (GERD) devices that provide long-term symptom alleviation and lessen the requirement for continued medication or repeated procedures are likely to save money.
Patients and healthcare professionals are now more aware of GERD and its possible consequences, which has resulted in earlier diagnosis and treatment commencement. This facilitates the adoption of gastroesophageal reflux disease devices by creating a favorable atmosphere.
Attributes
Details
Market Value for 2019
USD 1001 million
Market Value for 2023
USD 1213.4 million
Market CAGR from 2019 to 2023
3.9%
Impediments Impacting the Gastroesophageal Reflux Disease (GERD) Device Industry
Many people with GERD symptoms are unaware that they have the illness, which results in underdiagnosis and undertreatment. Insufficient knowledge among patients and medical professionals impedes the adoption of GERD devices.
GERD device reimbursement policies is complicated and varied amongst healthcare systems. Patient access and healthcare provider uptake are hampered by limited coverage and reimbursement choices.
New GERD devices cannot reach the market sooner due to drawn-out approval processes caused by strict regulatory regulations and the demand for extensive clinical data. This acts as an impediment to gastroesophageal reflux disease (GERD) device market expansion.
Get Brochure on Email
Almost 80% of our clients request uniquely tailored intelligence.
Category-wise Outlook
The segmented study of the gastroesophageal reflux disease (GERD) device market is detailed in the part below. Extensive research demonstrates that diagnostic procedures are at the forefront of procedural innovations, with esophagoscopes and gastroscopes commanding the product segment.
This comprehensive analysis sheds light on the constantly shifting landscape of GERD management, identifying major trends and in the gastroesophageal reflux disease device market.
The Leading Role of Esophagoscopes and Gastroscopes in GERD Device Market
Segment
Esophagoscopes and Gastroscopes
Share (2024)
90%
Esophagoscopy and gastroscopy segments are crucial diagnostic instruments that provide exact vision to detect and manage GERD accurately.
The business need for effective diagnostic procedures drives sales of gastroscopes and esophagoscopes in the gastroesophageal reflux disease (GERD) device market.
As a crucial component of the diagnostic toolkit, gastroscopes and esophagoscopes support market leadership by meeting the increasing demand for sophisticated GERD evaluation.
Healthcare providers' need is encouraged by the demand for GERD device diagnostic techniques, which provide crucial insights for customized treatment programs.
Diagnostic technology investments are drawing investors and healthcare providers as they align with the increased emphasis on value-based healthcare.
The leading position in gastroesophageal reflux disease (GERD) device sales of the diagnostic procedures category highlights its critical function in determining the treatment options available for GERD.
Country-wise Analysis
The GERD device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for gastroesophageal reflux disease device.
Opportunities in the Asia Pacific Gastroesophageal Reflux Disease (GERD) Device Industry
Countries
CAGR (2024 to 2034)
India
5.2%
Thailand
5.0%
Malaysia
4.6%
Indonesia
3.4%
India Industry Outlook
The gastroesophageal reflux disease (GERD) device industry in India likely expand even more due to government attempts to encourage medical travel and draw in foreign investment in the medical field.
There is an increasing need for novel and reasonably priced devices in India as the number of GERD cases being identified and treated rises.
Thailand Industry Outlook
As Thailand grows in popularity as a destination for medical treatments, the country's growing medical tourism industry is fueling the demand for gastroesophageal reflux disease (GERD) devices.
The adoption of GERD devices in Thailand is boosted by a growing patient and healthcare professional awareness of GERD and its treatment alternatives.
Malaysia Industry Outlook
Adopting cutting-edge medical treatments and technologies governs the demand for GERD devices in Malaysia's healthcare industry.
Malaysian individuals' and healthcare professionals' growing awareness of GERD and its repercussions surges the GERD device market.
Indonesia Industry Outlook
The increased prevalence of GERD is caused by changes in living choices and rising disposable income, which is propelling the gastroesophageal reflux disease device market in Indonesia.
The adoption of GERD devices is increasing in Indonesia due to patients' and healthcare providers' growing knowledge of GERD and available treatments.
Insights into Sales Performance of Gastroesophageal Reflux Disease (GERD) Device in North America
Countries
CAGR (2024 to 2034)
United States
2.6%
Canada
2.9%
United States Industry Outlook
The gastroesophageal reflux disease (GERD) device market dynamics are significantly shaped by health insurance coverage and reimbursement policies in the United States, which affects patient accessibility and affordability.
The emphasis on enhancing quality of life and patient preference for non-surgical alternatives are important reasons propelling the adoption of GERD devices in the United States.
Canada Industry Outlook
A wider adoption of GERD devices is supported by the Canadian healthcare system's emphasis on universal access to medical services, which guarantees fair availability for patients from various demographic backgrounds.
The introduction and adoption of gastroesophageal reflux disease devices in Canada are significantly shaped by regulatory frameworks and approval procedures prioritizing safety and efficacy.
Opportunities for Gastroesophageal Reflux Disease (GERD) Device Market in Europe
Countries
CAGR (2024 to 2034)
Germany
1.9%
United Kingdom
1.6%
France
2.3%
Italy
2.0%
Spain
2.9%
Germany Industry Outlook
The demand for GERD devices is expanding in Germany due to proactive healthcare activities and increased awareness.
Significant industry participants and a strong regulatory environment bolster German gastroesophageal reflux disease (GERD) device sales.
The Germany gastroesophageal reflux disease (GERD) device market is growing due to rising GERD prevalence and strong patient acceptance of minimally invasive procedures.
United Kingdom Industry Outlook
Growing rates of GERD are encouraging market expansion in the United Kingdom due to the adoption of new medical technology.
Proactive health education campaigns raise awareness and encourage early intervention, influencing the United Kingdom's sales of gastroesophageal reflux disease (GERD) device.
France Industry Outlook
The growing awareness of GERD by the general public and healthcare professionals contributes to the French demand for modern GERD devices.
The gastroesophageal reflux disease device market in France benefits from a rising emphasis on customized treatment solutions and a trend toward personalized medicine.
Italy Industry Outlook
Adopting telemedicine and digital health solutions in Italy has increased gastroesophageal reflux disease (GERD) device accessibility and usage.
The growing demand for GERD devices is fueled by Italy's preventative care-focused healthcare system, which presents opportunities for market expansion of gastroesophageal reflux disease (GERD) device.
Spain Industry Outlook
A cultural trend in Spain toward proactive health management and a growing acceptance of innovative medical technologies benefit the GERD device market.
The gastroesophageal reflux disease device market in Spain demonstrates an increasing need for individualized treatment plans, motivated by a better knowledge of each patient's requirements.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Competitive Analysis
Several prominent gastroesophageal reflux disease device vendors are vying for market share in the highly competitive atmosphere of the industry.
Notable gastroesophageal reflux disease device manufacturers influencing the direction of the business are Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG, Medtronic Plc, Fujifilm Holdings Corporation, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. By addressing the difficulties associated with managing GERD, these gastroesophageal reflux disease device businesses offer a variety of technological expertise, creating a competitive atmosphere centered on enhancing patient outcomes and expanding available treatment options.
Olympus Corporation, Pentax Medical, KARL STORZ SE, and Co KG are improving GERD device technology. This gastroesophageal reflux disease (GERD) device providers are known for their dedication to quality and innovation. Medtronic Plc uses its broad healthcare portfolio to provide comprehensive solutions for managing GERD, while Fujifilm Holdings Corporation contributes its imaging expertise to improve diagnostic capabilities.
By providing specialized tools and methods that address particular patient demands and broaden the range of available treatments, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. make contributions.
Continuous innovation and development in GERD management tactics are expected as these major gastroesophageal reflux disease device vendors cooperate and compete. These gastroesophageal reflux disease device suppliers are essential in influencing the direction of GERD therapy and enhancing the lives of those impacted by the disease by emphasizing patient-centric solutions and technical innovations.
Notable Strides
Company
Details
Wockhardt Ltd.
Wockhardt Ltd. acquired its authorized generic versions of several over-the-counter medications from Glenmark Pharmaceuticals Ltd. in June 2022. The approved abbreviated new drug applications for famotidine tablets, which are used to treat and prevent stomach and intestinal ulcers, as well as treatment drug Lansoprazole delayed-release capsules USP, 15 mg, are among the medications included in the acquisition by the company's fully owned subsidiary Glenmark Pharmaceuticals Inc, USA.
Zydus Lifesciences
The FDA approved Zydus Lifesciences' 20 mg and 40 mg formulations of metronidazole tablets for sale in June 2022. As a histamine H2 receptor blocker, famotidine lowers stomach acid production. The medication is intended to treat and prevent acid reflux disease (GERD) as well as other related symptoms.
Peptest
Peptest, a non-invasive radiofrequency device designed by RD Biomed for the diagnosis of reflux devices, was approved by China. This device detects pepsin in saliva samples and helps with the overall treatment of reflux-related devices.
EsophyX Z
An improved and more recent version of the EsophyX device is the EsophyX Z gastroesophageal reflux disease device, used to perform transoral incisionless fundoplication.
